Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Study on gene mutation in benign familial neonatal epilepsy

A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

Genetic Analysis of Benign Familial Epilepsies in the First Year of Life in a Chinese Cohort

[Spectrum of Mutations in Benign Familial Neonatal-Infantile Epilepsy].

Study of Pathogenic gene spectrum in benign familial infantile epilepsy

Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

[A Novel Mutation of KCNQ2 Gene in a Chinese Family with Benign Familial Neonatal Convulsions].

[A Novel Mutation in KCNQ2 Gene Causes Benign Familial Infantile Convulsions (BFIC) in a Chinese Family].

Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2

Rational Search for Genes in Familial Cortical Myoclonic Tremor with Epilepsy, Clues from Recent Advances.

Clinical and Genetic Analysis of Two Chinese Families with Benign Familial Neonatal Convulsions

Research Proression of Kv7 and Benign Familial Neonatal Convulsions

Phenotypes and PRRT2 mutation analysis in families with benign familial infantile epilepsy

Mutation Detection in Candidate Genes for Benign Familial Infantile Seizures on a Novel Locus.

Clinical and genetic analysis of Chinese patients with KCNQ2 mutation－induced neonatal/infantile epileptic disorders

H258R mutation in KCNAB3 gene in a family with genetic epilepsy and febrile seizures plus

Gene Mutation Analysis In 253 Chinese Children With Unexplained Epilepsy And Intellectual/Developmental Disabilities

[A Novel Mutation in KCNB1 Gene in a Child with Neuropsychiatric Comorbidities with Both Intellectual Disability and Epilepsy and Review of Literature].

[Genetic and Clinical Analysis of Children with Early-Onset Epilepsy Encephalopathy Caused by KCNT1 Gene Mutation].

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases